Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana

Martin Awe Akilla, Ignatius Abowini Awinibuno Nchor, Moses Banyeh, Nafiu Amidu

Open source

DOI
10.1002/iid3.1142
Published
2024-01
Container
Immunity, Inflammation and Disease
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/iid3.1142,
  title = {Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana},
  author = {Martin Awe Akilla and Ignatius Abowini Awinibuno Nchor and Moses Banyeh and Nafiu Amidu},
  year = {2024},
  journal = {Immunity, Inflammation and Disease},
  doi = {10.1002/iid3.1142},
  url = {https://doi.org/10.1002/iid3.1142}
}

RIS

TY  - JOUR
TI  - Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana
AU  - Martin Awe Akilla
AU  - Ignatius Abowini Awinibuno Nchor
AU  - Moses Banyeh
AU  - Nafiu Amidu
PY  - 2024
JO  - Immunity, Inflammation and Disease
DO  - 10.1002/iid3.1142
UR  - https://doi.org/10.1002/iid3.1142
ER  - 

APA

Akilla, M. A., Nchor, I. A. A., Banyeh, M., & Amidu, N. (2024). Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1142

Source records